Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.480
-0.050 (-3.27%)
At close: Jun 13, 2025, 4:00 PM
1.441
-0.039 (-2.64%)
After-hours: Jun 13, 2025, 7:54 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $419.27 million as of June 13, 2025. Its market cap has decreased by -36.17% in one year.
Market Cap
419.27M
Enterprise Value
59.00M
1-Year Change
-36.17%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $419.27M, a decrease of -77.44%. That is a compound annual growth rate of -31.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 419.27M | -40.92% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.99B |
| Johnson & Johnson | 376.94B |
| Novo Nordisk | 357.59B |
| AbbVie | 339.89B |
| UnitedHealth Group | 288.92B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 232.37B |